[Level of copper and zinc in plasma of patients with lung cancer].

Microelements metabolic disorders, including copper and zinc, constitute an important field of cancer studies. Efforts are undertaken to identify cancer markers. Found changes in plasma copper and zinc levels in patients with lung carcinoma may have clinical implications, and help in the diagnosis despite the fact that there are no reports in the literature confirming specificity of these two elements for lung carcinoma.

[Long-term survival of patients with small cell lung cancer].

The analysis of clinical determinants of long-term survival in small cell lung cancer was investigated in consecutive series of 469 patients included in prospective multicenter clinical trials from 1981 to 1985. Forty eight patients (19.2%) were alive after 2 years from initiation of therapy and among them 27 (5.